FDA approval of Opill makes it the first oral contraceptive that may be used without a prescription. Clinicians say over-the-counter availability will lower barriers to access to a key component of reproductive healthcare.
Also, the Mylan-Perrigo hostile takeover is underway, Medtronic gets an FDA approval and new population health innovations are popping up throughout the country.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
TOP STORIES Despite criticism and disapproval by some, the president gives Obamacare an 8 out of 10 rating – not giving it a ten because you can “always improve something.” “Sixteen million people or more have health insurance that didn’t have it before,” Obama said. He added that has led to the lowest uninsured rate […]
By Kurt R. Karst – In a Complaint filed last Friday in the U.S. District Court for the District of Columbia, Perrigo Israel Pharmaceuticals Ltd. and Perrigo Company (collectively “Perrigo”) (represented by Hyman, Phelps & McNamara, P.C.) allege that FDA has shirked a duty under the Federal Food, Drug, and Cosmetic Act (“FDC Act”) by […]
Generic drug company Synthon Pharmaceuticals has received tentative U.S. Food and Drug Administration approval on its application to make a version of UCB‘s (EBR:UCB) allergy medicine Xyzal. Netherlands-based Synthon, which has its U.S. headquarters and laboratories in Research Triangle Park, North Carolina, said it is seeking to bring a generic version of Xyzal oral solution […]
Analysts saw the acquisition as a sharp move by Perrigo and the company's stock responded in kind, rising to an all-time high. Perrigo purchased Paddock for roughly twice its revenue -- the final price is $445 million after certain tax benefits -- even though Paddock is in a fast-growing, high-margin niche and had recent revenue growth of more than 20 percent, according to Morningstar.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Perrigo Co. has reached a $48 million agreement to acquire an Australian over-the-counter, store-brand pharmaceuticals supplier. Perrigo, which bills itself as the world’s largest manufacturer of over-the-counter drugs for the store-brand market, says the purchase of Orion Laboratories Pty Ltd. will add about $30 million annually to its sales, according to a statement from Perrigo. […]